Tumor types with low Treg density might associate with effective therapeutic efficacy mediated by CTLA4 blockade, but further studies such as comparison of pre- and post-treatment Treg densities in different kinds of tumor types are required to elucidate this hypothesis. This evidence concerns the gene CTLA4 and neoplasm.